Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Sep 30, 2023
Revenue in the reported quarter decreased compared with both the immediately preceding quarter and the same quarter one year earlier. The year-over-year decline was less pronounced than in the prior quarter.
Key takeaway
Quarter ended Sep 30, 2023 · FY2023 Q3
Revenue in the reported quarter decreased compared with both the immediately preceding quarter and the same quarter one year earlier. The year-over-year decline was less pronounced than in the prior quarter.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.6B
Revenue reported for this quarter.
Quarter-over-quarter
-1.1%
Change from the immediately preceding quarter.
Year-over-year
-1.0%
Change from the comparable year-ago quarter.
Trailing four quarters
$43.4B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $11.5B | +7.0% |
| Apr 1, 2023 | $10.7B | -9.4% |
| Jul 1, 2023 | $10.7B | -2.6% |
| Sep 30, 2023 | $10.6B | -1.0% |
Revenue performance
The reported quarter's revenue fell relative to the prior quarter, continuing a sequential decline. The year-over-year comparison also showed a decrease, though at a smaller magnitude than the previous quarter's year-over-year drop.
Quarterly comparison
Compared with the immediately preceding quarter, revenue was lower. Versus the same quarter one year earlier, revenue also declined, with the year-over-year contraction moderating from the prior period's year-over-year change.
What to watch
After a sharp year-over-year decline in the prior quarter, the reported quarter's year-over-year decrease moderated, potentially indicating a stabilizing trend.